Find by identifier
CAS number index
39,377 CAS Registry Numbers in numeric order. A number with several grades opens a comparison page, a single match opens the product.
| CAS number | Substance | Listings |
|---|---|---|
| 104870-56-6 | (+)-Isopulegol | 1 |
| 104872-06-2 | (3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone | 1 |
| 104872-28-8 | (R,S,S,S)-Orlistat | 1 |
| 104873-71-4 | 1,2:4,5-Biscyclohexylidene DL-myo-Inositol | 1 |
| 104874-50-2 | (+/-)-11-Nor-9-Tetrahydrocannabinol | 1 |
| 104874-57-9 | Melphalan Isopropyl Ester | 1 |
| 104874-86-4 | S-Doxazosin | 1 |
| 104889-13-6 | Bis(tert-butyldicylcohexylphosphine)dichloropalladium(II) | 1 |
| 104933-99-5 | Gestodene EP Impurity J | 1 |
| 104934-50-1 | Poly(3-hexylthiophene-2,5-diyl) | 2 |
| 104934-51-2 | Poly(3-octylthiophene-2,5-diyl), electronic grade, 99.995% | 1 |
| 104953-06-2 | Terfenadine EP Impurity G | 1 |
| 104987-11-3 | Tacrolimus | 2 |
| 104987-12-4 | Ascomycin | 1 |
| 104987-16-8 | Tacrolimus Diene | 1 |
| 104987-30-6 | Tacrolimus EP Impurity E | 1 |
| 104993-28-4 | Fondaparinux | 1 |
| 105012-15-5 | 22-Hydroxy Mifepristone | 1 |
| 105024-66-6 | Silafluofen | 1 |
| 105047-45-8 | Fmoc-Lys-OH, ≥98% | 1 |
| 105066-20-4 | Sucralose EP Impurity G | 1 |
| 105086-92-8 | (R)-2-Amino-5-methoxytetraline | 1 |
| 105102-22-5 | Mometasone Furoate | 1 |
| 105167-27-9 | [R-(R*,S*)]-α-[(1-Carboxyethyl)amino]-γ-oxo-benzenebutanoic Acid Monoethyl Ester | 1 |
| 105170-27-2 | 2-Bromo-5-methoxypyridine | 1 |
| 105176-70-3 | Doxylamine Di-N-Oxide | 1 |
| 105184-38-1 | 3,5-Difluorophenylacetic Acid | 1 |
| 105186-33-2 | Tibolone EP Impurity E | 1 |
| 105186-34-3 | 10β-Peroxy ∆4-Tibolone | 1 |
| 105186-35-4 | 10-β-Hydroxy 4-Tibolone | 1 |
| 105227-28-9 | Alloursodeoxycholic acid | 1 |
| 105260-10-4 | Benazepril Impurity 2 | 1 |
| 105300-40-1 | Rac-6-Fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic acid | 1 |
| 105310-47-2 | (1R,2R)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide Hydrochloride | 1 |
| 105310-73-4 | rac-N-Desethyl-N'-phthalimido Milnacipran | 1 |
| 105310-75-6 | Rel-(1R,2S)-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropanecarboxamide | 1 |
| 105314-53-2 | Atomoxetine Impurity B | 1 |
| 105330-94-7 | 6-Methyl-5-Azacytosine Pentose | 1 |
| 105351-70-0 | Tanshinlactone | 1 |
| 105355-26-8 | Pioglitazone Imino Impurity | 1 |
| 105356-89-6 | Terazosin EP Impurity G | 1 |
| 105356-90-9 | Terazosin EP Impurity H | 1 |
| 105383-68-4 | 4-(2,3-Dichlorophenyl)-2,6-dimethyl-3-pyridinecarboxylic acid methyl ester | 1 |
| 105392-20-9 | Ciprofloxacin Intermediate 1 | 1 |
| 105394-83-0 | Ciprofloxacin EP Impurity E | 1 |
| 105410-48-8 | Tenoxicam EP Impurity G | 1 |
| 105440-01-5 | Norfloxacin EP Impurity H | 1 |
| 105454-04-4 | Paclitaxel EP Impurity E | 1 |
| 105460-59-1 | 4-tert-Butyldimethylsilyloxybenzeneacetic Acid Methyl Ester | 1 |
| 105462-23-5 | Risedronate EP Impurity B | 1 |
| 105462-24-6 | Risedronic acid | 1 |
| 105462-25-7 | Risedronate EP Impurity C | 1 |
| 105484-55-7 | Ethyl 8-chlorooctanoate | 1 |
| 105496-33-1 | 5-Hydroxy Buspirone | 1 |
| 105497-63-0 | L-Daunosamine, Hydrochoride | 1 |
| 105512-06-9 | Clodinafop Propargyl | 1 |
| 105520-53-4 | 26-Hydroxy-3,6,9,12,15,18,21,24-octaoxahexacosyl 4-(butylamino)benzoate | 1 |
| 105536-22-9 | 2,4,6-Triisopropylbenzenesulphonamide, extra pure >98% | 1 |
| 105562-12-7 | Cortisol Impurity B ((E)-17-deoxyaldehyde derivative) | 1 |
| 105562-13-8 | Cortisol Impurity C ((Z)-17-deoxyaldehyde derivative) | 1 |
| 105590-97-4 | L-Glutamic acid γ-benzyl ester α-tert-butyl ester hydrochloride, >98% | 1 |
| 105601-04-5 | 3-[1-(Dimethylamino)ethyl]phenol | 1 |
| 105612-58-6 | 6,11-Dihydroxy-8-(2-hydroxyacetyl)-1-methoxytetracene-5,12-dione | 1 |
| 105613-90-9 | Fluticasone Propionate EP Impurity E | 1 |
| 105638-31-1 | Fluticasone Impurity 4 | 1 |
| 105650-23-5 | 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine | 1 |
| 105684-85-3 | 1-(Benzofuran-4-yl)piperazine hydrochloride | 1 |
| 105688-01-5 | Xenocoumacin 1 | 1 |
| 105732-50-1 | 2-Tert-Butyl-2-methyl-1,3-benzodioxole | 1 |
| 105743-53-1 | (S)-2-Amino-2,4-dimethylpentanoic acid | 1 |
| 105746-38-1 | Nateglinide Impurity 2 | 1 |
| 105746-45-0 | Nateglinide EP Impurity E | 1 |
| 105764-07-6 | Tamsulosin EP Impurity E | 1 |
| 105779-78-0 | Pyrimidifen | 1 |
| 105809-15-2 | Ultramark 1621 | 1 |
| 105812-81-5 | Trans-(-)-Paroxol / (-)-trans-4-(4-Fluorophenyl)-N-methyl-3-hydroxymethylpiperidine | 1 |
| 105813-13-6 | Paroxetine EP Impurity C HCl | 1 |
| 105813-14-7 | Paroxetine Hydrochloride Anhydrous EP Impurity C, N-Benzyl Paroxetine | 1 |
| 105813-39-6 | Paroxetine EP Impurity F | 1 |
| 105816-04-4 | Nateglinide | 1 |
| 105816-05-5 | Nateglinide EP Impurity B | 1 |
| 105816-06-6 | Nateglinide EP Impurity C | 1 |
| 105826-92-4 | Tropisetron Hydrochloride | 1 |
| 105827-91-6 | 2-Chloro-5-(Chloromethyl)Thiazole | 1 |
| 105832-38-0 | N,N,N′,N′-Tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate, 97% | 1 |
| 105843-36-5 | Imidaclothiz | 1 |
| 105850-77-9 | 5-Chloromethyl-2-furoyl chloride | 1 |
| 105882-69-7 | Erythromycin EP Impurity F | 1 |
| 105900-46-7 | Pseudoerythromycin A Hemiketal | 1 |
| 105906-07-8 | (4-tert-Butylcyclohexyl)acetic acid | 1 |
| 105919-00-4 | 2-(3-Ethylureido)-2-oxoacetic Acid | 1 |
| 105926-34-9 | Methyl 5H-dibenzo[b,f]azepine-5-carboxylate | 1 |
| 105931-73-5 | 4-Bromo-2-fluoro-1-iodobenzene | 1 |
| 105942-08-3 | 4-Bromo-2-fluorobenzonitrile | 1 |
| 105956-97-6 | Clinafloxacin | 1 |
| 105957-88-8 | 4-Benzyl-2-nitroaniline | 1 |
| 105959-56-6 | N-(1-Phenylethyl) Ibuprofen Amide | 1 |
| 105979-17-7 | Benidipine | 1 |
| 106006-84-2 | Pramipexole EP Impurity E | 1 |
| 106007-99-2 | 2-(2-(Ethylamino)ethoxy)ethan-1-ol | 1 |
| 106008-69-9 | Tiacumicin F | 1 |
| 106040-48-6 | Tribenuron | 1 |
| 106083-71-0 | (S,S)-Hydroxy Bupropion Hydrochloride | 1 |
| 106092-09-5 | Pramipexole EP Impurity A | 1 |
| 106092-10-8 | Pramipexole EP Impurity A (DiHydrochloride Salt) | 1 |
| 106092-11-9 | (R)-N-Despropyl Pramipexole | 1 |
| 106111-42-6 | Dienogest EP Impurity C | 1 |
| 106111-43-7 | Dienogest EP Impurity K | 1 |
| 106133-20-4 | Tamsulosin | 1 |
| 106135-28-8 | 5-Methoxy-1H-benzimidazole-2-sulfonic acid | 1 |
| 106138-88-9 | Tamsulosin EP Impurity G | 1 |
| 106139-15-5 | S-2-Pyridylthio Cysteamine Hydrochloride | 1 |
| 106148-95-2 | Benzyl | 1 |
| 106175-03-5 | 1-(Benzo[d][1,3]dioxol-5-yl)-4,4-dimethylpentan-3-ol | 1 |
| 106214-84-0 | Poly(dimethylsiloxane), bis(3-aminopropyl) terminated average Mn ~2500 | 2 |
| 106236-80-0 | N-(5-Methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide | 1 |
| 106261-48-7 | Imatinib Impurity 1 | 1 |
| 106261-49-8 | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride | 1 |
| 106261-64-7 | 4-(4-Methylpiperazin-1-ylmethyl)benzoyl chloride Dichydrochloride | 1 |
| 106266-04-0 | (2,4-Difluorophenyl)(piperidin-4-yl)methanone hydrochloride | 1 |
| 106266-06-2 | Risperidone | 1 |
| 106266-08-4 | Methyl 5,6,7,8-Tetradehydro Risperidone | 1 |
| 106266-09-5 | Risperidone EP Impurity K | 1 |
| 106308-41-2 | 6-Desfluoro Rufinamide | 1 |
| 106308-44-5 | Rufinamide | 1 |
| 106308-60-5 | 2,6-Difluorobenzyl Azide | 1 |
| 106310-22-9 | 1-Methyl-3-(3-methyl-4-(4-((trifluoromethyl)thio)phenoxy)phenyl)urea | 1 |
| 106391-86-0 | (R)-tert-Butyl (1-hydroxypropan-2-yl)carbamate | 1 |
| 106433-44-7 | Famotidine EP Impurity C | 1 |
| 106447-44-3 | Cefprozil EP Impurity D | 1 |
| 106447-97-6 | 2-Amino-4-(trifluoromethyl)pyridine, 97% | 1 |
| 106461-41-0 | Itraconazole Hydroxy Isobutyltriazolone Impurity | 1 |
| 106463-17-6 | Tamsulosin HCl | 2 |
| 106463-19-8 | Tamsulosin S-Isomer Hydrochloride Salt | 1 |
| 106495-57-2 | Cerium magnesium aluminate, terbium doped, 99% | 1 |
| 106498-32-2 | (S)-β-Isopropylphenethylamine | 1 |
| 106500-25-8 | Azadirachtin B, 98% | 1 |
| 106505-90-2 | Boldenone cypionate | 1 |
| 106516-24-9 | Sertindole | 1 |
| 106614-28-2 | 2,4-Difluoro-benzoic acid methyl ester | 1 |
| 106614-66-8 | Amorolfine EP Impurity F | 1 |
| 106627-54-7 | N-Hydroxysulphosuccinimide sodium salt, ≥98% (HPLC) | 1 |
| 106635-81-8 | Tafenoquine Succinate | 1 |
| 106647-49-8 | Sulindac Sulfide Methyl Ester | 1 |
| 106649-02-9 | 1-Methyl-1H-indazole-3-carbonyl Chloride | 1 |
| 106649-95-0 | N-Sulphamyl-3-Chloro Propionamidine Hydrochloride | 1 |
| 106649-96-1 | Famotidine Ep Impurity H | 1 |
| 106656-90-0 | Hydroxychloroquine Hydroxy Intermediate | 1 |
| 106658-09-7 | Isopropyl-d7 Amine | 1 |
| 106685-40-9 | Adapalene | 1 |
| 106685-41-0 | Adapalene Methyl Ester | 1 |
| 106685-43-2 | Methyl 6-(3-((3r,5r,7r)-adamantan-1-yl)-4-hydroxyphenyl)-2-naphthoate | 1 |
| 106700-29-2 | Pethoxamid | 1 |
| 106765-04-2 | 6,7-Dehydro Norethindrone Acetate | 1 |
| 106778-43-2 | Isoquinoline-6-carboxylic acid | 1 |
| 106791-37-1 | Triclabendazole Sulfone | 1 |
| 106797-53-9 | 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone, 98% | 1 |
| 106799-07-9 | Amphoteronolide B | 1 |
| 106820-63-7 | Methyl 3-(N-(2-methoxy-2-oxoethyl)sulfamoyl)thiophene-2-carboxylate | 1 |
| 106860-19-9 | Cilazapril EP Impurity A | 1 |
| 106861-44-3 | Mivacurium chloride | 1 |
| 106877-20-7 | 3-Methoxy-4-(trifluoromethyl)phenylamine | 1 |
| 106877-30-9 | 3-Methyl-2-(trifluoromethyl)aniline | 1 |
| 106877-31-0 | 3-Methyl-4-(trifluoromethyl)aniline | 1 |
| 106877-41-2 | 3-Methoxy-4-(trifluoromethyl)phenol | 1 |
| 106890-70-4 | Orbifloxacin EP Impurity F | 1 |
| 106900-12-3 | Loperamide EP Impurity F | 1 |
| 106916-16-9 | Ropinirole EP Impurity D | 1 |
| 106917-52-6 | Flusulfamide | 1 |
| 106928-09-0 | Cilazapril EP impurity D | 1 |
| 106931-78-6 | Fluocinolone Acetonide EP Impurity A | 1 |
| 106939-34-8 | Levofloxacin Impurity 10 | 1 |
| 106941-25-7 | Adefovir | 1 |
| 106944-63-2 | N-(Isopropylcarbamoyl)-4-(p-tolylamino)pyridine-3-sulfonamide | 1 |
| 107007-95-4 | Granisetron EP Impurity B | 1 |
| 107007-99-8 | Granisetron Hydrochloride | 1 |
| 107017-73-2 | Cyclopropylacetylene Stage-6 | 1 |
| 107021-38-5 | X-α-Gal | 1 |
| 107049-57-0 | Trimetazidine EP Impurity A Dihydrochloride | 1 |
| 107112-93-6 | 6,7-Dihydrothieno[3,2-c]pyridine | 1 |
| 107133-36-8 | Perindopril Erbumine | 1 |
| 107140-32-9 | (5S,8S,11S)-11-Amino-8-(2-amino-2-oxoethyl)-16-methoxy-7,10-dioxo-2-oxa-6,9-diaza-1(1,3),3(1,4)-dibenzenacyclododecaphane-5-carboxylic Acid | 1 |
| 107201-33-2 | Benzyl methyl(2-oxoethyl)carbamate | 1 |
| 107220-26-8 | Cevimeline Thiol Impurity | 1 |
| 107220-28-0 | Cevimeline Hydrochloride | 1 |
| 107220-29-1 | trans-Cevimeline Hydrochloride | 1 |
| 107228-51-3 | 3,6-Dichloro-4-Isopropylpyridazine | 1 |
| 107233-08-9 | Cevimeline | 1 |
| 107245-26-1 | 1-(Dimethylamino)-6-methylheptan-3-one | 1 |
| 107256-32-6 | 4-[[3-[2-(3-Chlorophenyl)ethyl]-2-pyridinyl]carbonyl]-1-piperidinecarboxylic Acid Ethyl Ester | 1 |
| 107257-20-5 | Ketoprofen EP Impurity D | 1 |
| 107259-05-2 | Cyclopropylacetylene Stage-5 | 1 |
| 107259-06-3 | Cyclopropylacetylene Stage-7 | 1 |
| 107259-48-3 | Aristolochic Acid E | 1 |
| 107317-58-8 | Siponimod Impurity-1 | 1 |
| 107362-46-9 | BenzeneethanaMine, a-[2-(1-piperidinyl)phenyl] | 1 |
| 107382-51-4 | Z-Norgestimate | 1 |
| 107382-52-5 | E-Norgestimate | 1 |
| 107389-91-3 | Cleroindicin B | 1 |
| 107393-73-7 | 2,3,4,5-Tetrahydro-1H-3-benzazepin-7-amine | 1 |
| 107408-36-6 | (E)-6-Chlorohex-2-enoic Acid | 1 |
| 107430-57-9 | 4-(6-Methoxynaphthalen-2-yl)benzoic Acid | 1 |
| 107431-14-1 | N,N,3,3-Tetramethyl-1,5-dioxaspiro[5.5]undecan-9-amine | 1 |
| 107438-79-9 | Ginkgolide J | 1 |
| 107474-79-3 | (+)-1-(9-Fluorenyl)ethyl chloroformate | 1 |
| 107512-34-5 | 4-Chloro-3-methoxy-2-methyl-pyridine | 1 |
| 107512-35-6 | Pantoprazole Impurity-1 (RRT~0.65) | 1 |
| 107534-93-0 | Anwuligan | 1 |
| 107534-96-3 | Tebuconazole | 1 |
| 107538-91-0 | Sertraline EP Impurity C | 1 |
| 107538-97-6 | (1RS,4SR)-4-(4-Chlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | 1 |
| 107539-20-8 | Yttrium barium copper oxide, 99.9% | 1 |
| 107552-14-7 | Scandium nitrate, hydrate, 99.9% | 2 |
| 107596-30-5 | S-(+)-Mecamylamine Hydrochloride | 1 |
| 107596-31-6 | R-(-)-Mecamylamine Hydrochloride | 1 |
| 107605-95-8 | Caffeine EP Impurity E Hydrochloride (Caffeidine Hydrochloride) | 1 |
| 107625-61-6 | 2,3,3,5,5-Pentamethyloctane | 1 |
| 107648-80-6 | Cefepime Hydrochloride | 1 |
| 107650-20-4 | 5-Bromo-2-methyl-3-nitrobenzoic Acid | 1 |
| 107667-60-7 | Polaprezinc, ≥97% | 1 |
| 107668-79-1 | Bulleyaconitine A | 1 |
| 107674-50-0 | Norfluoxetine Oxalate | 1 |
| 107724-20-9 | Eplerenone | 1 |
| 107745-70-0 | Acetic Acid-13C2, D3 | 1 |
| 107753-78-6 | Zafirlukast | 1 |
| 107754-15-4 | Zafirlukast-ZAF-4A | 1 |
| 107754-19-8 | 4-[[5-[[(Cyclopentyloxy)carbonyl]amino]-1-methyl-1H-indol-3-yl]methyl]-3-methoxy-benzoic acid methyl ester | 1 |
| 107759-10-4 | 2-(2,3-Dihydroxy-3,7,11,15-tetramethylhexadecyl)-3-methylnaphthalene-1,4-dione | 1 |
| 107783-45-9 | Coccinic acid | 1 |
| 107814-37-9 | Ambroxol EP Impurity D | 1 |
| 107833-98-7 | Nicorandil N-Oxide | 1 |
| 107868-30-4 | Exemestane | 1 |
| 107868-36-0 | 4-Chloro Exemestane | 1 |
| 107870-05-3 | Quinovin | 1 |
| 107873-05-2 | (Z)-7-(((S)-2-Amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic acid | 1 |
| 107878-38-6 | Rel - Fenoterol EP Impurity A | 1 |
| 107880-74-0 | Famotidine EP Impurity F | 1 |
| 107884-22-0 | Enrofloxacin Butyl Ester Impurity | 1 |
| 107910-75-8 | Ganciclovir Sodium | 1 |
| 107937-01-9 | Cefprozil Monohydrate - Impurity F | 1 |
| 108014-19-3 | N-Desmethyl cyamemazine | 1 |
| 108015-78-7 | 5-(2-Oxido-1,2-dithiolan-3-yl)pentanoic Acid | 1 |
| 108027-39-0 | Cyclosporin L | 1 |
| 108027-44-7 | Cyclosporin T | 1 |
| 108027-45-8 | Cyclosporin U | 1 |
| 108027-46-9 | Cyclosporin V | 1 |
| 108048-37-9 | rac-2,3-Dihydro-6-methoxy-1H-indene-1-ethanamine | 1 |
| 108050-54-0 | Tilmicosin | 1 |
| 108052-76-2 | tert-Butyl 4-(bromomethyl)benzoate, 95% | 1 |
| 108061-03-6 | Ketorolac EP Impurity J | 1 |
Or browse by name